CDER Ombudsman Warren Rumble Inherits Increasing Complaints
One of the issues facing CDER Acting Ombudsman Warren Rumble is a rise in internal complaints at the drug center
You may also be interested in...
Roche's response to a question about Accutane-associated psychosis asked at the company's exhibit booth during the American Pharmaceutical Association annual meeting minimizes the drug's risk of psychiatric disorders, an FDA ad division letter says
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials